Site logo
Sticky header logo
Mobile logo
  • À propos du projet
    • Le projet
    • Modules de travail
    • Qui sommes nous
      • Partenaires du consortium
      • Les Membres du Consortium
  • Le progrès
  • Nouvelles
  • Resources
  • FrançaisFrançais
    • EnglishEnglish
    • EspañolEspañol
    • PortuguêsPortuguês

Resources

Dr Clara Menéndez – ISGlobal

Dr. Francisco Saúte – Mozambique, CISM

Dr. Augustin Fombah – Ministry of Health Sierra Leone and ISGlobal

Key publications on IPTi

 

  1. WHO. World malaria report. WHO 2019; Available at

https://www.who.int/publications/i/item/9789241565721

 

  1. WHO. WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for

Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. World Health Organization. 2012; Available at :

https://www.who.int/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf

 

  1. WHO. WHO Policy recommendation on intermittent preventive treatment during

infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa. World Health Organization. 2010; Available at :

https://www.who.int/malaria/news/WHO_policy_recommendation_IPTi_032010.pdf?ua=1

 

  1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, et al. Efficacy

and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in

African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet (London, England). 2009;374(9700):1533-42. Available at:

https://pubmed.ncbi.nlm.nih.gov/19765816/

 

  1. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, et al. The cost-effectiveness

of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PloS one.

2010;5(6):e10313. Available at:

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010313

 

  1. Esu EB, Oringanje C, Meremikwu MM. Intermittent preventive treatment for malaria in

infants. The Cochrane database of systematic reviews. 2019;12(12):Cd011525. Available at: https://pubmed.ncbi.nlm.nih.gov/31792925/

 

  1. WHO. GLOBAL TECHNICAL STRATEGY FOR MALARIA 2016–2030. World Health

Organization. 2015. Available at : https://www.who.int/docs/default-source/documents/global-technical-strategy-for-malaria-2016-2030.pdf

 

  1. Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, et al. Molecular

markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment

for malaria in Mozambican infants. The Journal of infectious diseases. 2008;197(12):1737-42. Available at:

https://academic.oup.com/jid/article/197/12/1737/867000

 

  1. Alexander N, Sutherland C, Roper C, Cissé B, Schellenberg D. Modelling the impact of

intermittent preventive treatment for malaria on selection pressure for drug resistance.

Malaria journal. 2007;6:9. Available at:

https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-6-9

 

  1. O’Meara WP, Smith DL, McKenzie FE. Potential impact of intermittent preventive

treatment (IPT) on spread of drug-resistant malaria. PLoS medicine. 2006;3(5):e141. Available at:

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030141

 

  1. Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, et al. Association of

transmission intensity and age with clinical manifestations and case fatality of severe

Plasmodium falciparum malaria. Jama. 2005;293(12):1461-70. Available at: https://pubmed.ncbi.nlm.nih.gov/15784869/

 

  1. Roca-Feltrer A, Carneiro I, Smith L, Schellenberg JR, Greenwood B, Schellenberg D. The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings. Malaria journal. 2010;9:282. Available at: https://pubmed.ncbi.nlm.nih.gov/20939931/

 

  1. Crawley J, Sismanidis C, Goodman T, Milligan P. Effect of intermittent preventive

treatment for malaria during infancy on serological responses to measles and other vaccines

used in the Expanded Programme on Immunization: results from five randomised controlled

trials. Lancet (London, England). 2012;380(9846):1001-10. Available at: https://pubmed.ncbi.nlm.nih.gov/22850358/

 

  1. Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-Resistant

Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015. Emerging infectious diseases. 2018;24(1):40-8. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749434/

 

  1. WHO. Reported estimates of MCV1 coverage. 2020. Available at :

https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragemcv1.html

 

  1. Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, et al. Cost-

effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bulletin of the World Health Organization. 2009;87(2):123-9. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636201/

 

  1. UNICEF. Levels and Trends in Child Mortality. 2019; Available at

http://documents1.worldbank.org/curated/en/105841568905930695/pdf/Levels-and-Trends-in-Child-Mortality-Report-2019.pdf

Authors
  • All
  • All

SUPPORTED

This project is part of the EDCTP2 programme supported by the European Union
 

M

  • À propos du projet
    • Le projet
    • Modules de travail
    • Qui sommes nous
      • Partenaires du consortium
      • Les Membres du Consortium
  • Le progrès
  • Nouvelles
  • Resources
  • FrançaisFrançais
    • EnglishEnglish
    • EspañolEspañol
    • PortuguêsPortuguês
  • Politique de confidentialité
  • Mention légale
  • Politique de cookies
div#stuning-header .dfd-stuning-header-bg-container {background-image: url(https://multiplyipti.net/wp-content/uploads/2021/10/IMG-20210721-WA0013.jpg);background-color: transparent;background-size: cover;background-position: center center;background-attachment: initial;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 400px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Enregistrer & appliquer
Propulsé par CookieYes Logo